Putatively functional PLCE1 variants and susceptibility to esophageal squamous cell carcinoma (ESCC): A case-control study in eastern Chinese populations

Annals of Surgical Oncology

Volumn 19, Issue 7, 2012, Pages 2403-2410

  Hu, Haichuan ^a,b   Yang, Jingmin ^b   Sun, Yihua ^a,b   Yang, Yajun ^b,c   Qian, Ji ^b,c   Jin, Li ^b,c   Wang, Mengyun ^a,b   Bi, Rui ^a,b   Zhang, Ruoxin ^a,b   Zhu, Meiling ^a,b   Sun, Menghong ^a,b   Ma, Hongxia ^d   Wei, Qingyi ^d   Jiang, Guoliang ^a,b   Zhou, Xiaoyan ^a,b   Chen, Haiquan ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c CMC Institute of Health Sciences   (China)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PHOSPHOLIPASE; PLCE1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CANCER SUSCEPTIBILITY; CHINESE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHINA; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PHOSPHOINOSITIDE PHOSPHOLIPASE C; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84865129575     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2160-y     Document Type: Article

References (31)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108. (Pubitemid 40372904)
2. Lambert R, Hainaut P. The multidisciplinary management of gastrointestinal cancer. Epidemiology of oesophagogastric cancer. Best Pract Res Clin Gastroenterol. 2007;21:921-45.
3. Vaughan TL, Davis S, Kristal A, Thomas DB. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 1995;4:85-92.
4. Fan Y, Yuan JM, Wang R, Gao YT, Yu MC, et al. Alcohol, tobacco, and diet in relation to esophageal cancer: the Shanghai Cohort Study. Nutr Cancer. 2008;60:354-63. (Pubitemid 351601371)
5. Ribeiro U, Jr., Posner MC, Safatle-Ribeiro AV, Reynolds JC. Risk factors for squamous cell carcinoma of the oesophagus. Br J Surg. 1996;83:1174-85. (Pubitemid 26290441)
6. Chang-Claude J, Becher H, Blettner M, Qiu S, Yang G, Wahrendorf J. Familial aggregation of oesophageal cancer in a high incidence area in China. Int J Epidemiol. 1997;26:1159-65. (Pubitemid 28010432)
7. Hu N, Dawsey SM, Wu M, Bonney GE, He LJ, Han XY, et al. Familial aggregation of oesophageal cancer in Yangcheng County, Shanxi Province, China. Int J Epidemiol. 1992;21:877-82. (Pubitemid 23366729)
8. Li XY, Su M, Huang HH, Li H, Tian DP, Gao YX. mtDNA evidence: genetic background associated with related populations at high risk for esophageal cancer between Chaoshan and Tai-hang Mountain areas in China. Genomics. 2007;90:474-81. (Pubitemid 47404798)
9. Hiyama T, Yoshihara M, Tanaka S, Chayama K. Genetic polymorphisms and esophageal cancer risk. Int J Cancer. 2007;121: 1643-58. (Pubitemid 47417279)
10. Xing D, Tan W, Lin D. Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (review). Oncol Rep. 2003;10:1615-23.
11. Cui R, Kamatani Y, Takahashi A, Usami M, Hosono N, Kaw-aguchi T, et al. Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. Gastroenterology. 2009;137:1768-75.
12. Hu N, Wang C, Hu Y, Yang HH, Giffen C, Tang ZZ, et al. Genome-wide association study in esophageal cancer using GeneChip mapping 10 K array. Cancer Res. 2005;65:2542-6. (Pubitemid 40490048)
13. Wang LD, Zhou FY, Li XM, Sun LD, Song X, Jin Y, et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet. 2010;42:759-63.
14. Abnet CC, Freedman ND, Hu N, Wang Z, Yu K, Shu XO, et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric ade-nocarcinoma and esophageal squamous cell carcinoma. Nat Genet. 2010;42:764-7.
15. Bunney TD, Katan M. Phospholipase C epsilon: linking second messengers and small GTPases. Trends Cell Biol. 2006;16:640-8. (Pubitemid 44809889)
16. Rhee SG. Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem. 2001;70:281-312. (Pubitemid 32662212)
17. Katan M. New insights into the families of PLC enzymes: looking back and going forward. Biochem J. 2005;391:e7-9.
18. Wing MR, Bourdon DM, Harden TK. PLC-epsilon: a shared effector protein in Ras-, Rho-, and G alpha beta gamma-mediated signaling. Mol Interv. 2003;3:273-80.
19. Li M, Edamatsu H, Kitazawa R, Kataoka T. Phospholipase Cepsilon promotes intestinal tumorigenesis of Apc(Min/?) mice through augmentation of inflammation and angiogenesis. Carci-nogenesis. 2009;30:1424-32.
20. Bai Y, Edamatsu H, Maeda S, Saito H, Suzuki N, Satoh T, et al. Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development. Cancer Res. 2004;64:8808-10. (Pubitemid 39665481)
21. Ou L, Guo Y, Luo C, Wu X, Zhao Y, Cai X. RNA interference suppressing PLCE1 gene expression decreases invasive power of human bladder cancer T24 cell line. Cancer Genet Cytogenet. 2010;200:110-9.
22. Wang X, Zbou C, Qiu G, Fan J, Tang H, Peng Z. Screening of new tumor suppressor genes in sporadic colorectal cancer patients. Hepatogastroenterology. 2008;55:2039-44.
23. Bourguignon LY, Gilad E, Brightman A, Diedrich F, Singleton P. Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2 ? signaling, and cyto-skeleton modification in head and neck squamous cell carcinoma cells. J Biol Chem. 2006;281:14026-40. (Pubitemid 43848329)
24. Zhang H, Jin G, Li H, Ren C, Ding Y, Zhang Q, et al. Genetic variants at 1q22 and 10q23 reproducibly associated with gastric cancer susceptibility in a Chinese population. Carcinogenesis. 2011;32:848-52.
25. Sons HU. Etiologic and epidemiologic factors of carcinoma of the esophagus. Surg Gynecol Obstet. 1987;165:183-90. (Pubitemid 17151753)
26. Wang X, Lu M, Qian J, Yang Y, et al. Rationales, design and recruitment of the Taizhou Longitudinal Study. BMC Public Health. 2009;9:223.
27. Xu ZL, Taylor JA. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res. 2009;37:W600-W5.
28. Tran GD, Sun XD, Abnet CC, Fan JH, Dawsey SM, Dong ZW, et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer. 2005;113:456-63. (Pubitemid 40038715)
29. Kamangar F, Chow WH, Abnet CC, Dawsey SM. Environmental causes of esophageal cancer. Gastroenterol Clin North Am. 2009;38:27-57, vii.
30. Sorli SC, Bunney TD, Sugden PH, Paterson HF, Katan M. Signaling properties and expression in normal and tumor tissues of two phospholipase C epsilon splice variants. Oncogene. 2005;24: 90-100. (Pubitemid 40143868)
31. Wang X, Zhou C, Qiu G, Yang Y, Yan D, Xing T, et al. Phos-pholipase C epsilon plays a suppressive role in incidence of colorectal cancer. Med Oncol. 2011 Epub ahead of print.